Acetylcysteine

Nisha Patel, PharmD, MBA, BCPS, Alona Crowder, Pharm.D.

INDICATIONS

FDA

  • Adjuvant mucolytic therapy for patients with abnormal, viscid, or inspissated mucous secretions secondary to respiratory diseases such as emphysema, tuberculosis, bronchitis or for treatment of respiratory complications of cystic fibrosis and tracheostomy care.

NON-FDA APPROVED USES

  • Nephrotoxicity prophylaxis (focus of this module)
  • Acetaminophen overdose

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: July 3, 2020